NFKB1 and cancer: Furthermore, this is the first report of a strategy comprising the combination of NTP with another anticancer agent in cancer cells to alleviate invasive characteristics (migration/invasion) which are closely associated with locally advancement of tumor or distant metastasis.In normal cells, quiescent NF-κB is activated by inflammatory stimuli.